Oracle Corporation (NYSE:ORCL) is among the 12 Tech Stocks with Best Earnings Growth in 2026. On March 16, Mizuho trimmed the price target on Oracle Corporation (NYSE:ORCL) to $320 from $400 and reiterated an Outperform rating. According to the firm, the company delivered a “clean” third quarter, surpassing estimates across the board and raising its FY27 revenue target to $90 billion. This was higher than the consensus forecast. While associating the price drop with multiple contractions, the firm believes ...

Oracle Corporation (NYSE:ORCL) is among the best stocks in each sector in 2026. As of February 23, Oracle Corporation (NYSE:ORCL) is a buy according to 77% of analysts covering the stock. While the price target ranges from $155 to $400, the 1-year median price target reflects an upside potential of 94.61%. Among those bullish on the stock is Michael Turrin of Wells Fargo, who maintained a Buy rating on the company and set a price target of $280 on February 23. Is Oracle Corporation (ORCL) The Best Stock ...

Core Insights - A strategic partnership has been formed between Oracle Health, Cleveland Clinic, and G42 to develop an AI-based healthcare delivery platform aimed at enhancing patient care and public health management [1][2][6] Group 1: Partnership Objectives - The partnership aims to create a global AI-powered healthcare platform that combines Oracle's cloud infrastructure and AI data platform with Cleveland Clinic's clinical expertise and G42's AI capabilities [2][4] - The initiative is designed to address the evolving healthcare needs of global populations, starting with the U.S. and the UAE, by delivering secure, scalable, and intelligent healthcare solutions [2][7] Group 2: Technological Innovations - The platform will utilize AI to analyze population health data in real-time, providing clinicians with actionable insights at the point of care [3][4] - It aims to enhance diagnostics, personalize treatments, optimize outcomes, and reduce costs, thereby improving overall healthcare quality [7][8] Group 3: Impact on Healthcare Delivery - The collaboration seeks to eliminate silos between clinical research and care, facilitating easier identification of clinical trial candidates and access to real-world data for researchers [4][6] - The initiative is expected to transform healthcare delivery by making it more data-driven, affordable, and accessible, ultimately benefiting global health systems [6][8]